<DOC>
	<DOCNO>NCT02550314</DOCNO>
	<brief_summary>To assess efficacy safety regeneration treatment tympanic membrane NPC-18 FBG-18 .</brief_summary>
	<brief_title>A Study Regenerative Treatment Tympanic Membrane With NPC-18 FBG-18</brief_title>
	<detailed_description />
	<mesh_term>Tympanic Membrane Perforation</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>1 . Written inform concent obtain 2 . At time obtain informed consent , Ages range 20 80 3 . At time obtain informed consent , tympanic membrane perforation 1 ear ( ) 6 month ( perforation ear exclude ) 1 . TMP cause burn radiation therapy 2 . In patient chronic otitis medium ear drum perforation , tympanic cavity dry 3 . Inflammatory , infection otorrhea patient 's eardrum , earcanal , middle ear tympanic cavity 4 . No invasion epithelial cholesteatoma tympanic cavity around perforate edge 5 . History tympanoplasty 6 . A Part eardrum adhere tympanic cavity 7 . By temporal bone CT , soft tissue shadow mastoid antrum tympanic ( use CT image le 12 wks patient registration ) 8 . Abnormality chain ear ossicles 9 . Airbone gap difference 25dB patch hear test 10 . Unable see whole edge TMP due narrow external auditory canal 11 . Unable wash Ear drop treatment period 12 . Presenting uncontrolled diabetes ( NGSP HbA1c 6.9 % ) 13 . Presenting autoimmune disease 14 . History malignancy within 3 year prior obtain informed concent 15 . Administration immunosuppressive agent anticanceragent 16 . History Allergic reaction local anesthetic ( Xylocaine ) , bFGF ( Fiblast spray ) , fibrin glue ( Beriplast P Combi set , etc . ) , gelatin sponge formulation ( spongel ) others 17 . Though period screen treatment , patient unable wash `` Thrombolytic agent '' , `` Anticoagulant '' , `` Antiplatelet agent '' , `` Procoagulant agent '' , `` antiline solvent '' '' aprotinin formulation ''</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>